Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET
Titel:
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET
Auteur:
Straus, David J. Johnson, Jeffrey L. LaCasce, Ann S. Bartlett, Nancy L. Kostakoglu, Lale Hsi, Eric D. Schöder, Heiko Hall, Nathan C. Jung, Sin-Ho Canellos, George P. Schwartz, Lawrence H. Takvorian, Ronald W. Juweid, Malik E. Cheson, Bruce D.